<DOC>
	<DOCNO>NCT00615446</DOCNO>
	<brief_summary>This study assess maximum tolerated dose , overall safety antitumor activity SU011248 combination gemcitabine patient advance solid tumor</brief_summary>
	<brief_title>A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Patients diagnosis solid cancer responsive standard therapy standard therapy exist Patient good performance status ( ECOG 0 1 ) Prior treatment either gemcitabine SU011248 Hypertension control medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>solid tumor malignancy , SU011248 , sunitinib , neoplasm</keyword>
</DOC>